Along with Tregs and MDSCs, PD-1 causes immunosuppression in HCC [145], and these data may provide a rationale for the adjuvant usage of combination therapy, including PD-L1/VEGF blockade, in addition to curative therapies. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.